Neoadjuvant therapy with immunotherapy in pMMR/MSS rectal cancer shows high response rates and favorable surgical outcomes, with manageable safety profiles. Short-course chemoradiotherapy demonstrates ...
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology, today announced that preliminary results from an investigator-sponsored study evaluating botensilimab (BOT) in combination with balstilimab ...
MSS Inc., a Tennessee-based manufacturer of sensor-based sorting technology for the recycling and waste management sector, has announced its official relocation to a new facility at 1101 Menzler Road, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results